[11, 12, 14] Further studies in CLL and other leukemias suggest that flavopiridol mediates its cytotoxic effects through inhibition of positive transcription elongation factor b (P-TEFb, CDK9/cyclin T) via CDK9 and hence hampering global RNA transcription. Here, CDK9 is linked to leukemia.